MarketCap
Facebook
X
TelegramAnnual report 2024
added 03-04-2025
Nevro Corp. ROCE Ratio 2011-2026 | NVRO
Annual ROCE Ratio Nevro Corp.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -54.64 | -33.88 | 1.9 | -36.54 | -16.18 | -24.18 | -10.42 | -7.47 | -5.94 | -24.48 | -14.77 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.9 | -54.64 | -20.6 |
Quarterly ROCE Ratio Nevro Corp.
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -36.04 | -39.92 | -39.46 | -29.7 | -4.44 | 29.77 | 28.12 | 1.28 | -13.27 | -53.08 | -47.13 | -25.1 | -25.32 | -11.68 | -16.39 | -16.18 | -21.35 | -27.83 | -31.0 | -44.59 | -42.7 | -39.07 | -30.14 | -17.0 | -14.37 | -12.38 | -13.03 | -11.87 | -13.52 | -12.5 | -10.89 | -9.27 | -12.35 | -19.15 | -24.95 | -26.59 | -25.11 | -21.34 | -17.5 | -16.45 | -4.7 | 5.32 | 9.66 | 13.87 | 6.25 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 29.77 | -53.08 | -17.4 |
ROCE Ratio of other stocks in the Medical devices industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
-182.32 | $ 2.11 | - | $ 3.29 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
5.98 | $ 10.42 | - | $ 1.41 B | USA |
 |
Allied Healthcare Products
AHPI
|
-24.19 | - | 3.58 % | $ 2.21 M | USA |
 |
Butterfly Network
BFLY
|
-44.07 | $ 3.91 | - | $ 828 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-6.16 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
1334.24 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-89.32 | - | 24.59 % | $ 44.8 M |  China |
 |
CONMED Corporation
CNMD
|
9.93 | $ 37.41 | - | $ 1.16 B | USA |
 |
Alphatec Holdings
ATEC
|
-660.94 | $ 12.6 | - | $ 1.89 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-191.02 | - | -5.86 % | $ 30.6 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
6.76 | $ 8.38 | - | $ 602 M |  Israel |
 |
Aziyo Biologics
AZYO
|
-97.25 | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-3.22 | $ 3.96 | 1.02 % | $ 148 M |  France |
 |
Avinger
AVGR
|
268.22 | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
7261.94 | - | -13.19 % | $ 166 K | USA |
 |
Boston Scientific Corporation
BSX
|
14.91 | $ 69.79 | - | $ 103 B | USA |
 |
Establishment Labs Holdings
ESTA
|
-165.66 | $ 63.48 | - | $ 1.88 B |  Costa-rica |
 |
Conformis
CFMS
|
-85.42 | - | - | $ 16.4 M | USA |
 |
Apollo Endosurgery
APEN
|
-96.4 | - | - | $ 475 M | USA |
 |
Helius Medical Technologies
HSDT
|
-528.85 | $ 2.19 | - | $ 1.33 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-151.13 | $ 0.65 | -8.13 % | $ 35.4 M | USA |
 |
Cutera
CUTR
|
-60.43 | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
0.33 | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
-75.2 | - | 14.99 % | $ 929 K | USA |
 |
IRIDEX Corporation
IRIX
|
-105.09 | $ 1.33 | - | $ 21.5 M | USA |
 |
ClearPoint Neuro
CLPT
|
-77.77 | $ 11.03 | - | $ 298 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-804.35 | - | 1.15 % | $ 34.5 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-11.39 | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
-46.49 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-124.26 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-22.41 | - | 0.03 % | $ 1.58 B | Israel |
 |
LivaNova PLC
LIVN
|
16.62 | $ 61.43 | - | $ 3.35 B |  Britain |
 |
Misonix, Inc.
MSON
|
-10.4 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-344.26 | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
2.84 | $ 18.42 | 0.22 % | $ 121 M | USA |
 |
InMode Ltd.
INMD
|
12.27 | $ 13.43 | - | $ 868 M | Israel |
 |
MiMedx Group
MDXG
|
24.9 | $ 4.41 | - | $ 652 M | USA |
 |
GBS
GBS
|
-355.28 | - | -0.57 % | $ 7.12 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-36.94 | - | - | $ 955 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-28.95 | $ 2.59 | - | $ 152 M | Israel |
 |
Abbott Laboratories
ABT
|
15.45 | $ 109.95 | - | $ 191 B | USA |
 |
Delcath Systems
DCTH
|
0.59 | $ 9.81 | - | $ 351 M | USA |
 |
Bio-Rad Laboratories
BIO
|
4.09 | $ 261.24 | - | $ 7.37 B | USA |
 |
Insulet Corporation
PODD
|
31.27 | $ 224.66 | - | $ 15.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.84 | $ 9.01 | - | $ 694 M | USA |
 |
Profound Medical Corp.
PROF
|
-18.9 | $ 5.71 | - | $ 180 M | Canada |
 |
AxoGen
AXGN
|
-6.09 | $ 32.84 | - | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
15.77 | $ 169.45 | - | $ 12.7 B | USA |
 |
Bruker Corporation
BRKR
|
14.21 | $ 32.76 | - | $ 4.88 K | USA |
 |
AVITA Medical
RCEL
|
255.46 | $ 4.62 | 5.0 % | $ 129 M |  Australia |